FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

232811000001108: Cefalexin 250mg tablets (Ranbaxy (UK) Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16276701000001117 Cefalexin 250mg tablets (Ranbaxy (UK) Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
16276801000001114 Cefalexin 250mg tablets (Ranbaxy (UK) Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cefalexin 250mg tablets (Ranbaxy (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cefalexin 250mg tablets (Ranbaxy (UK) Ltd) Is a Product containing precisely cefalexin monohydrate 250 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Cefalexin 250mg tablets (Ranbaxy (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Cefalexin 250mg tablets (Ranbaxy (UK) Ltd) Is a Cefalexin 250mg tablets true Inferred relationship Existential restriction modifier
Cefalexin 250mg tablets (Ranbaxy (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cefalexin 250mg tablets (Ranbaxy (UK) Ltd) Is a Cefalexin 250mg tablets false Inferred relationship Existential restriction modifier
Cefalexin 250mg tablets (Ranbaxy (UK) Ltd) Has active ingredient Bactericide false Inferred relationship Existential restriction modifier
Cefalexin 250mg tablets (Ranbaxy (UK) Ltd) Has active ingredient Cefalexin false Inferred relationship Existential restriction modifier
Cefalexin 250mg tablets (Ranbaxy (UK) Ltd) Has active ingredient Substance with antibacterial mechanism of action false Inferred relationship Existential restriction modifier
Cefalexin 250mg tablets (Ranbaxy (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cefalexin 250mg tablets (Ranbaxy (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cefalexin 250mg tablets (Ranbaxy (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Cefalexin 250mg tablets (Ranbaxy (UK) Ltd) Has specific active ingredient Cefalexin true Inferred relationship Existential restriction modifier
Cefalexin 250mg tablets (Ranbaxy (UK) Ltd) Has active ingredient Cefalexin monohydrate false Inferred relationship Existential restriction modifier
Cefalexin 250mg tablets (Ranbaxy (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Cefalexin 250mg tablets (Ranbaxy (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Cefalexin 250mg tablets (Ranbaxy (UK) Ltd) 28 tablet 4 x 7 tablets Is pack of False Cefalexin 250mg tablets (Ranbaxy (UK) Ltd) Inferred relationship Existential restriction modifier
Cefalexin 250mg tablets (Ranbaxy (UK) Ltd) 28 tablet 4 x 7 tablets Has AMP True Cefalexin 250mg tablets (Ranbaxy (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start